Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple Sclerosis

被引:38
|
作者
Healy, Brian C. [1 ,2 ]
Engler, David [3 ]
Glanz, Bonnie [1 ]
Musallam, Alexander [1 ]
Chitnis, Tanuja [1 ]
机构
[1] Brigham & Womens Hosp, Partners MS Ctr, Harvard Med Sch, 1 Brookline Pl, Brookline, MA 02445 USA
[2] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA
[3] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA
关键词
D O I
10.1155/2013/189624
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sustained progression on the expanded disability status scale (EDSS) is a common outcome measure of disease progression in clinical studies of MS. Unfortunately, this outcome may not accurately measure long-term and irreversible disease progression. To assess the performance of definitions of sustained progression, patients with relapsing-remitting MS (RRMS) or a clinically isolated syndrome with evidence of lesions on a brain MRI were included in our study. Fifteen definitions of sustained progression using both the EDSS and the functional system (FS) scales were investigated. The impact of both relapses and changes in provider on the probability of maintaining progression was also evaluated. Although the provider scoring the EDSS sometimes changed during followup, the provider had access to previous EDSS scores. Between 15.8% and 42.2% of patients experienced sustained progression based on the definitions using EDSS as the outcome, but nearly 50% of these patients failed to maintain sustained progression for the duration of followup. When FS scales were used, progression was most common on the pyramidal and sensory scales. Unfortunately, progression on specific FS scales failed to be more sensitive to irreversible disability. Relapses or changes in provider did not explain the poor performance of the measures. Short-term changes in the EDSS or FS scores may not be an accurate marker of irreversible change in RRMS.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Assessment of clinical definitions of conversion of relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis
    Diaz-Cruz, Camilo
    Healy, Brian
    Chua, Alicia
    Bhattacharyya, Shamik
    Kimbrough, Dorlan
    Severson, Christopher
    Stankiewicz, James
    Sattarnezhad, Neda
    Glanz, Bonnie
    Weiner, Howard
    Chitnis, Tanuja
    [J]. NEUROLOGY, 2017, 88
  • [2] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762
  • [3] The impact of pregnancy on progression of relapsing-remitting multiple sclerosis
    Karp, I.
    Manganas, A.
    Sylvestre, M. -P.
    Roger, E.
    Ho, A.
    Duquette, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 102 - 103
  • [4] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [5] Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis
    Rudick, Richard A.
    Lee, Jar-Chi
    Cutter, Gary R.
    Miller, Deborah M.
    Bourdette, Dennis
    Weinstock-Guttman, Bianca
    Hyde, Robert
    Zhang, Hao
    You, Xiaojun
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (11) : 1329 - 1335
  • [6] The effects of immunomodulatory treatments on the progression of relapsing-remitting multiple sclerosis
    Candan, E
    Yilmaz, Z
    Canturk, IA
    Isik, N
    Yildiz, N
    Seleker, T
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S234 - S235
  • [7] Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis
    Pasca, Matteo
    Forci, Benedetta
    Mariottini, Alice
    Mechi, Claudia
    Barilaro, Alessandro
    Massacesi, Luca
    Repice, Anna Maria
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [8] The association between disease activity and disability progression in patients with relapsing-remitting multiple sclerosis
    Spelman, T.
    Geale, K.
    Anell, B.
    Hillert, J.
    Wong, S. L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 127 - 128
  • [9] Expansion of chronic lesions is linked to disease progression in relapsing-remitting multiple sclerosis patients
    Klistorner, Samuel
    Barnett, Michael H.
    Yiannikas, Con
    Barton, Joshua
    Parratt, John
    You, Yuyi
    Graham, Stuart L.
    Klistorner, Alexander
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (10) : 1533 - 1542